Ashwagandha Withanolide Claims: What HPLC Testing Actually Finds in Raw Material Shipments

Every month, supplement brands across the Midwest place purchase orders for ashwagandha extract with CoAs showing 5%, 8%, even 10% withanolides. A number that looks reassuring on paper — until the actual shipment arrives at an analytical testing laboratory and the HPLC data comes back at 2.8%.

That gap isn’t a rounding error. It’s a methodological one. And understanding exactly why it happens is the difference between a product that performs as labeled and one that quietly underdelivers — or worse, surfaces in an FDA compliance inquiry.

Ashwagandha (Withania somnifera) has become one of the most commercially significant adaptogens in the US supplement market, with global sales projected to exceed $1.2 billion by 2028. With that growth has come enormous pressure on the supply chain — and on the analytical claims suppliers attach to their raw materials.

Why “5% Withanolides” on a CoA Is Often Meaningless Without Method Disclosure

Withanolides are a class of steroidal lactones — roughly 35+ identified compounds — found primarily in the root, though also concentrated in the leaves of Withania somnifera. Withaferin A, withanolide D, and withanolide A are among the most pharmacologically studied. But here’s the problem: when a supplier writes “5% withanolides” on a CoA, they haven’t told you which withanolides were measured, whether the calculation was by mass or by peak area, or — most critically — which analytical method was used to arrive at that figure.

Two widely used methods produce dramatically different numbers from the same sample:

• Colorimetric assays (variants of the vanillin-sulfuric acid or Carr-Price methods) detect total steroidal content in a crude, non-specific way. They can’t distinguish withanolides from other sterols present in the plant matrix. The result: systematically inflated readings, sometimes 30–50% higher than what HPLC would show on the identical sample.
• HPLC separates the extract’s individual compounds chromatographically and quantifies specific withanolide peaks against certified reference standards. It’s specific, reproducible, and method-transferable. It’s also what USP calls for — the United States Pharmacopeia dietary supplement monograph for ashwagandha root extract specifically requires HPLC for withanolide quantification.

Yet a significant fraction of supplier CoAs in circulation today still don’t disclose the method used — because there’s no universal mandate forcing them to. Ask your current ashwagandha supplier what method generated their withanolide figure. Many can’t tell you on the spot.

How Colorimetric Assays Inflate Withanolide Readings — and Why Some Suppliers Default to Them

This isn’t always deliberate fraud. Colorimetric testing is older, faster, and cheaper to run than HPLC. For smaller suppliers operating an in-house lab with limited instrumentation, it’s often the inherited default. The problem is that the supplement industry — and brand liability expectations — have moved faster than some suppliers’ analytical capabilities.

The vanillin-sulfuric acid reaction measures anything with a steroidal backbone that produces a characteristic absorbance response. In an ashwagandha root extract, that includes plant sterols like β-sitosterol and stigmasterol, which have no pharmacological relevance to ashwagandha’s adaptogenic activity. A colorimetric “withanolide” number, then, is really a proxy for total steroidal content — a proxy that overstates actual withanolide concentration by a margin that varies batch to batch.

When our team receives incoming ashwagandha samples and runs them through HPLC quantification, discrepancies of 20–45% between the supplier-stated value and the verified value are not rare occurrences. They’re common enough that we treat every new supplier’s first two or three batches as requiring independent confirmation before they can enter a client’s approved supplier list.

This is especially telling when you compare generic commodity extracts to proprietary branded ingredients. KSM-66 (standardized to ≥5% total withanolides by HPLC, root-only material from Ixoreal Biomed) and Sensoril (≥10% withanolides plus ≥32% oligosaccharides from Natreon Inc., using root and leaf material) each publish their specifications with full method transparency and independently audited validation data. When a generic “ashwagandha root extract, 5% withanolides” arrives at a fraction of the price with a one-line CoA entry and no method notation — that price gap should prompt questions, not confidence.

Leaf vs. Root Adulteration: The Hidden Variable That Potency Screens Miss

A related issue HPLC testing regularly uncovers involves the source material itself. Ashwagandha leaf material contains higher total withanolide concentrations than root — by some measures, two to three times higher on a dry-weight basis. It’s also considerably cheaper to source and process.

Some suppliers blend leaf material into ostensibly root-only extracts to hit withanolide targets without the cost of using quality root. The resulting extract may pass a colorimetric assay at the 5% threshold. But its withanolide compound profile — and its phytochemical safety profile — differs meaningfully from a root-only extract.

HPTLC (high-performance thin-layer chromatography) can flag leaf-root blending through characteristic marker differences in the chromatographic fingerprint. The pattern of withaferin A relative to other marker compounds shifts noticeably when leaf material is present in quantity. Combined with HPLC for quantification, dual-method testing gives a far more complete picture than either method alone. Some analytical testing laboratories run both automatically on incoming ashwagandha shipments; others run only one if you don’t specifically request the additional tier. Know which you’re getting before the results land.

The safety distinction matters beyond compliance. Withaferin A — more concentrated in leaf extracts — has demonstrated cytotoxic properties at elevated doses in preclinical models. The long-standing traditional use data and human safety evidence for ashwagandha are based predominantly on root material. A product formulated and labeled as “ashwagandha root extract” that’s actually a root-leaf blend may not be fully substantiated by the same research base the label implies. That’s a regulatory exposure, not just a quality one.

The DSHEA Compliance Trap: When a Supplier CoA Can’t Support Your Label Claim

Under 21 CFR Part 111 — the FDA’s current Good Manufacturing Practice regulations for dietary supplements — you’re required to verify the identity, purity, strength, and composition of every incoming dietary ingredient before using it in production (§111.70(b)). Using a supplier’s CoA alone, without any independent testing or documented supplier qualification, isn’t technically sufficient if you can’t demonstrate you’ve assessed the supplier’s testing methodology.

More directly: if your finished product label states “250 mg ashwagandha root extract, standardized to 5% withanolides” and the verified withanolide concentration in your formulation is 2.8%, you have a misbranding exposure under Section 403 of the Federal Food, Drug, and Cosmetic Act. The FTC also has independent authority over label accuracy claims for supplements marketed with structure/function language. Neither agency requires a consumer complaint to initiate action — finished product testing is a documented component of FDA’s routine market surveillance program.

And if you’re an Amazon seller operating under the Amazon Supplement Compliance Program, third-party test results now carry direct listing consequences. An HPLC-verified CoA from an ISO 17025-accredited analytical testing laboratory carries weight that a supplier’s in-house colorimetric result simply doesn’t — and Amazon’s compliance reviewers know the difference.

The practical liability picture: if your withanolide claim is overstated and a competitor, retailer, or regulatory body pulls your product for independent testing, you’re holding an exposure your supplier quietly passed downstream.

What to Demand From Your Ashwagandha Supplier Before the Next Order Ships

You don’t need a PhD in analytical chemistry to ask the right questions. You need a short checklist and the discipline to follow through before the purchase order goes out. For any ashwagandha raw material, require the following:

1. Method disclosure on the CoA — Does it explicitly state HPLC or colorimetric? If the CoA doesn’t specify, ask in writing. The response — or the silence — is informative.
2. Compound-level withanolide breakdown — Total withanolides by HPLC should ideally be accompanied by individual quantification of withaferin A and withanolide D at minimum. This is standard practice for premium extracts and tells you far more than a single total figure.
3. Source material declaration — Root-only, or root and leaf blend? If root-only, confirm there’s a botanical identity test in the documentation file (HPTLC fingerprint or DNA barcoding, not just an organoleptic description).
4. Reference standard documentation — What calibration standard was used for HPLC quantification? Withaferin A reference standard from a traceable certified source (USP, Sigma-Aldrich, ChromaDex) versus an in-house preparation affects the reliability of every concentration number on that CoA.
5. ISO 17025 accreditation status of the testing laboratory — Supplier in-house labs are not automatically accredited and are not subject to external technical audits. Third-party accreditation means the method has been independently validated and the laboratory’s technical competence has been formally assessed.

If a supplier pushes back on any of these requests, treat that friction as a risk signal. Established, quality-conscious suppliers answer these questions without hesitation — because they’ve already built a documentation stack capable of supporting downstream brand requirements.

For Midwest supplement brands sourcing ashwagandha through Chicago-area distributors or direct import, incoming verification testing doesn’t have to add weeks to your timeline. Samples received at our Countryside, IL facility move directly into the testing queue — HPLC withanolide quantification with an ISO 17025-backed report typically returns within 5–7 business days.

Getting accurate potency data before you manufacture isn’t a precaution for cautious companies. Given the FDA’s sustained focus on dietary supplement label accuracy and the growth of third-party retail testing programs, it’s quietly becoming a baseline requirement for staying in the market.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025 Accreditation and What It Means for Your Supplement Test Results — How accredited methods and external audits translate into defensible CoAs for FDA and retail compliance.
• Botanical Supplier Qualification Under 21 CFR Part 111: Building an Approved Vendor List That Holds Up — A detailed guide to incoming material verification programs for US dietary supplement manufacturers.